These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 32563180)

  • 41. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.
    Van Elslande J; Houben E; Depypere M; Brackenier A; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P
    Clin Microbiol Infect; 2020 Aug; 26(8):1082-1087. PubMed ID: 32473953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
    Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
    Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
    [No Abstract]   [Full Text] [Related]  

  • 43. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
    Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
    Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef M; Imöhl M; Kleines M
    J Clin Virol; 2020 Jul; 128():104394. PubMed ID: 32416599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical evaluation of commercial automated SARS-CoV-2 immunoassays.
    Kittel M; Muth MC; Zahn I; Roth HJ; Thiaucourt M; Gerhards C; Haselmann V; Neumaier M; Findeisen P
    Int J Infect Dis; 2021 Feb; 103():590-596. PubMed ID: 33310108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity.
    Perkmann T; Perkmann-Nagele N; Breyer MK; Breyer-Kohansal R; Burghuber OC; Hartl S; Aletaha D; Sieghart D; Quehenberger P; Marculescu R; Mucher P; Strassl R; Wagner OF; Binder CJ; Haslacher H
    Clin Chem; 2020 Nov; 66(11):1405-1413. PubMed ID: 32777031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
    Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
    J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19.
    Imai K; Tabata S; Ikeda M; Noguchi S; Kitagawa Y; Matuoka M; Miyoshi K; Tarumoto N; Sakai J; Ito T; Maesaki S; Tamura K; Maeda T
    J Clin Virol; 2020 Jul; 128():104393. PubMed ID: 32387968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
    Tuaillon E; Bolloré K; Pisoni A; Debiesse S; Renault C; Marie S; Groc S; Niels C; Pansu N; Dupuy AM; Morquin D; Foulongne V; Bourdin A; Le Moing V; Van de Perre P
    J Infect; 2020 Aug; 81(2):e39-e45. PubMed ID: 32504735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
    Bryan A; Pepper G; Wener MH; Fink SL; Morishima C; Chaudhary A; Jerome KR; Mathias PC; Greninger AL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sensitivity, specificity, predictive values in serological Covid-19 tests].
    Duca P
    Epidemiol Prev; 2020; 44(2-3):189-190. PubMed ID: 32631019
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test.
    Andrey DO; Cohen P; Meyer B; Torriani G; Yerly S; Mazza L; Calame A; Arm-Vernez I; Guessous I; Stringhini S; Roux-Lombard P; Fontao L; Agoritsas T; Stirnemann J; Reny JL; Siegrist CA; Eckerle I; Kaiser L; Vuilleumier N;
    Eur J Clin Invest; 2020 Oct; 50(10):e13357. PubMed ID: 32691863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.
    Charlton CL; Kanji JN; Johal K; Bailey A; Plitt SS; MacDonald C; Kunst A; Buss E; Burnes LE; Fonseca K; Berenger BM; Schnabl K; Hu J; Stokes W; Zelyas N; Tipples G
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32665420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals.
    Wang H; Ai J; Loeffelholz MJ; Tang YW; Zhang W
    Emerg Microbes Infect; 2020 Dec; 9(1):2200-2211. PubMed ID: 32962560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
    Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid Detection of COVID-19 by Serological Methods and the Evaluation of Diagnostic Efficacy of IgM and IgG.
    Huang S; Lin C; Yan M; Li H; Liu T; Michael W; Xiang J; Shen C
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.